PRP for Knee Osteoarthritis

Is PRP Right for Your Knee?

Knee osteoarthritis is one of the most studied indications for platelet-rich plasma therapy — and the evidence, while generally positive, is genuinely mixed. Understanding both what PRP can offer and where its limitations lie is essential to making an informed decision. This page presents both sides of the current evidence honestly.

For patients in Walnut Creek and throughout the East Bay who are looking to manage knee pain, improve mobility, and delay or avoid surgery, PRP is treatment option.

From a research perspective, evidence supports PRP for improving pain and function in patients with mild to moderate knee osteoarthritis. There are also studies showing that not all patients respond. Dr. Murakami will review the current evidence alongside her clinical experience to discuss what is most appropriate for your specific condition.

What the Evidence Shows — The Case For PRP

The clinical evidence for PRP in knee osteoarthritis is the strongest of any PRP indication:

  • Multiple systematic reviews and meta-analyses incorporating over 3,000 patients in randomized controlled trials consistently demonstrate meaningful improvements in pain and function following PRP knee injections
  • PRP outperforms hyaluronic acid for functional improvement and provides more durable pain relief than corticosteroids over time, particularly at the 6 and 12-month marks
  • The American College of Rheumatology (ACR) and the Arthritis Foundation have recommended PRP for knee osteoarthritis since 2019
  • Benefits are most pronounced in patients with mild to moderate degeneration (Kellgren-Lawrence grades I–III)
  • A series of injections — typically 3 injections spaced one to two weeks apart — yields better outcomes than a single injection
  • Combining PRP with hyaluronic acid has demonstrated superior long-term outcomes compared to PRP alone, with PRP administered first followed by HA producing the best results

What the Evidence Shows — The Case for Caution

The picture is not uniformly positive, and patients deserve to know this:

  • A well-designed, large randomized controlled trial found no meaningful improvement with PRP compared to saline placebo — a significant negative result that cannot be dismissed
  • A comprehensive analysis of 29 systematic reviews found critically low methodological quality in the majority of them, with extensive overlap in the underlying trials — meaning the apparent consistency of positive findings may be partly an artifact of how studies have been pooled and reported
  • Individual positive trials are only modestly robust when subjected to fragility index analysis, and some systematic reviews have been found to overstate benefits
  • The American Academy of Orthopaedic Surgeons (AAOS) concluded that evidence supporting PRP use remains inconclusive due to inconsistent results and lack of standardized protocols
  • PRP carries a higher risk of local complications — including soreness, swelling, and rare infection — compared to saline placebo, though complication rates appear similar to hyaluronic acid and corticosteroid injections
  • Results are highly sensitive to patient selection, PRP preparation method, injection protocol, and individual biological factors including metabolic status and inflammation levels — meaning not all PRP is equivalent

What This Means for Patient Selection

The most clinically honest interpretation of the current evidence is this: PRP works well for some patients and not at all for others, and we do not yet have a reliable way to predict response in advance. What we do know is that the following patient characteristics are associated with better outcomes:

  • Mild to moderate knee osteoarthritis (Kellgren-Lawrence grades I–III)
  • Lower BMI and good metabolic health
  • Absence of severe structural damage or complete joint space loss
  • Prior failure of conservative treatments including physical therapy and oral medications
  • Realistic expectations about the timeline and magnitude of improvement

Candidacy is evaluated carefully during consultation — and PRP is recommended only when the clinical picture genuinely supports it.

How PRP Works in the Knee

A small blood sample is drawn and processed in a centrifuge to concentrate the platelets and their growth factors. The resulting platelet-rich plasma is injected directly into the knee joint under ultrasound guidance for accuracy and safety.

Once injected, platelets release growth factors and anti-inflammatory signaling proteins that may help reduce chronic synovial inflammation, support cartilage and soft tissue health, slow degenerative progression, and improve joint mobility. PRP does not regrow cartilage or reverse structural damage — it creates a pro-healing environment that addresses the underlying inflammatory drivers of pain.

Before Your Procedure

Avoid NSAIDs (such as ibuprofen, Mobic, naproxen, or Celebrex) for at least one week before and one week after your PRP injection. NSAIDs directly counteract the inflammatory signaling that drives PRP’s effectiveness.

What to Expect

The procedure is performed in-office under ultrasound guidance and typically takes under an hour. Most patients return to light activity the same day, with mild soreness at the injection site being the most common side effect. Improvements develop gradually — most patients notice meaningful changes within two to six weeks, with continued gains possible over several months.

From a Research & Clinical Perspective

From a research perspective, there is evidence to show that PRP helps treating pain and functionality for patients with mild to moderate knee osteoarthritis. There are also studies that are mixed or not positive. Dr. Murakami will address the scientific evidence, along with her clinical experience to discuss your specific condition with you.

Sources & Further Reading

The following peer-reviewed studies informed the content on this page. Links open in a new tab.

Supporting Evidence

Limitations and Negative Evidence

Comprehensive Reviews

Clinical Guidelines

  • American College of Rheumatology / Arthritis Foundation. PRP conditionally recommended for knee and hip osteoarthritis (2019 guidelines, reaffirmed).
  • American Academy of Orthopaedic Surgeons (AAOS). Evidence inconclusive due to inconsistent results and lack of standardized protocols.
  • Osteoarthritis Research Society International (OARSI). PRP classified as “uncertain” — positive symptomatic outcomes noted but high variability in trial design.

This page was last reviewed March 2026.

Knee PRP Consultation